
DR. Michael Lacount
Dr. Mike LaCount is Founder and CEO of Yield Scientific as well as Advising Managing Director at Frontcourt, a leading boutique healthcare and technology investment bank. He previously served as President and CEO at Arcus Medical, and as Interim CEO, Managing Director, and Vice Chairman for Elauwit. Mike has completed research fellowships with Wyeth-Ayerst Laboratories, Procter and Gamble Pharmaceuticals, and the Computational Crystallography Group at the Pittsburgh Supercomputing Center. He earned his Doctorate in Chemistry from the University of South Carolina and holds a B.S. in Chemistry from the State University of New York.
ZEB
PORTANOVA
Zeb Portanova is President of Yield Scientific and CEO of GEM Opportunity Zone Fund, an impact investment fund focused on opportunity zones in the USA. He was previously COO for Vestergaard, a global health company focused on malaria prevention and public health, and President / CEO of Swiss KRONO USA. Zeb has served on numerous boards of directors including the UN Global Compact Switzerland, Habitat for Humanity, and the Southern Carolina Regional Development Alliance. He earned his MBA from Duke University, a Master’s in Public Policy from Harvard University, and a Bachelor’s Degree from the University of Florida.
